Zurich, Switzerland

Miro Raeber

This inventor holds 1 USPTO granted patent. Top assignee: Unversität Zürich. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miro Raeber. Retrieved from https://idiyas.com/inventor/miro-raeber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miro Raeber: Innovator in Immunology

Introduction

Miro Raeber is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of immunology, particularly through his innovative research and development of antibodies.

Latest Patents

Miro Raeber holds a patent for a CD25-biased anti-IL-2 antibody. This invention represents a crucial advancement in therapeutic approaches for various diseases, showcasing his expertise and dedication to improving healthcare.

Career Highlights

Miro Raeber is affiliated with the Universität Zürich, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on immunotherapy and related fields.

Collaborations

Miro has collaborated with notable colleagues, including Onur Boyman and Ufuk Karakus. These partnerships have further enriched his research endeavors and contributed to the advancement of their shared goals in immunology.

Conclusion

Miro Raeber's contributions to the field of immunology through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to inspire advancements in medical science and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…